Sign inJoin free

Watch / Small Cap

EMVision's "brainwave" a step closer towards FDA approval

3 July 20258:12

EMVision's "brainwave" a step closer towards FDA approval

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Scott Kirkland, CEO of EMVision joined ausbiz.

The medical device maker has activated five out of six sites in its pivotal brain scanner trial, a major step toward FDA approval of its portable “emu” device. The trial, running across top-tier stroke centres in the US and Australia, targets up to 300 stroke patients over 6–12 months.

Mount Sinai in New York is the latest site to begin patient recruitment, while the sixth site is pending final approval. The company is also kicking off a Continuous Innovation Study in Brisbane and Newcastle, focused on stroke and traumatic brain injury patients.

EMVision’s bedside scanner uses non-ionising radiation to provide rapid neurodiagnostic insights without needing traditional CT or MRI scans—positioning it as a game-changer for stroke care in emergency settings.

Scott discussed EMVision's next steps with the First Responder program, as well as market opportunities for medical devices.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy